Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

Showing session: reset

Dolutegravir Resistance in Resource-Limited Settings

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7
Session Overview - Dolutegravir Resistance in Resource-Limited Settings
Gert U. van Zyl
Stellenbosch University, Cape Town, South Africa
from CROI 2024 on March 6, 2024 1:30 PM-2:30 PM
Viremia and Drug Resistance 2 Years After Routine Switching to Dolutegravir-Based First-Line ART   (ABSTRACT 676)
Richard J. Lessells
KwaZulu-Natal Research Innovation and Sequencing Platform, KRISP
from CROI 2024 on March 6, 2024 1:30 PM-2:30 PM
DTG Resistance in Patients with Previous ARV Experience and Viremia in Kenya Receiving DTG-Based ART   (ABSTRACT 677)
Leonard Kingwara
Ministry of Health, Nairobi, Kenya
from CROI 2024 on March 6, 2024 1:30 PM-2:30 PM
Emerging Dolutegravir Resistance in Lesotho   (ABSTRACT 678)
Niklaus D. Labhardt
University of Basel, Basel, Switzerland
from CROI 2024 on March 6, 2024 1:30 PM-2:30 PM
Resistance to Second-Generation InSTIs in Mexican PLWH: Emergence of the R263K Mutant   (ABSTRACT 679)
Luis Enrique Soto Ramírez
incmnsz
from CROI 2024 on March 6, 2024 1:30 PM-2:30 PM
Virologic Outcomes With Tenofovir-Lamivudine-Dolutegravir for PI-Based Second-Line ART Failure   (ABSTRACT 680)
Ying Zhao
University of Cape Town, Cape Town, South Africa
from CROI 2024 on March 6, 2024 1:30 PM-2:30 PM
Discussion with Audience Questions and Answers
from CROI 2024 on March 6, 2024 1:30 PM-2:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7